Latest News
From the Journals
Dieting and Gout: Intensive Weight Loss Not Especially Helpful for Symptoms
Researchers found an association between weight loss and a corresponding reduction in serum urate, but more weight loss did not result in positive...
Feature
Evidence Grows for SGLT2 Inhibitors in Rheumatology
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs...
From the Journals
Redosing Rituximab to Maintain ANCA Vasculitis Remission: When Is Best?
A single-center study found that using B-cell levels to determine when to infuse rituximab reduced relapses in patients antineutrophil cytoplasmic...
Latest News
Comments Disputed on Negative Low-Dose Naltrexone Fibromyalgia Trial
Neuroinflammation expert Jarred Younger, PhD, disputes commentary calling for clinicians to stop prescribing the off-label compounded medication...
Conference Coverage
ME/CFS and Long COVID: Research Aims to Identify Treatable, Druggable Pathways
A 2-day research conference sponsored by the US National Institutes of Health highlighted research that points to mechanisms that suggest...
Law & Medicine
Doctors in 2 More States May Qualify for Student Loan Forgiveness
Loan forgiveness has several qualifications.
News
Long COVID: New Info on Who Is Most Likely to Get It
People with a history of allergies, anxiety or depression, arthritis, and autoimmune diseases and women are among those who appear more vulnerable...
From the Journals
Monoclonal Antibodies: A New Treatment for Long COVID?
Three Florida patients with long COVID made complete — and sudden — recoveries after they were given the monoclonal antibody cocktail casirivimab/...
Latest News
Doctors Win $7 Million Settlement in EEOC Forced Retirement Case
“This policy was put in place to enhance patient safety,” Scripps said.
Feature
A New Test Could Save Arthritis Patients Time, Money, and Pain. But Will It Be Used?
“We are told by the insurer what to prescribe to the patient. After they fail methotrexate, it’s a TNF inhibitor, almost always Humira. And that’s...
Feature
Where Is the ‘Microbiome Revolution’ Headed Next?
Important advances are coming our way in the next 5-10 years.